Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,799 | -16,241 | -10,044 | -4,161 | -14,059 |
| Depreciation Amortization | 361 | 175 | 83 | 95 | 308 |
| Accounts receivable | -59 | N/A | N/A | -69 | N/A |
| Accounts payable and accrued liabilities | 1,360 | 3,304 | 351 | 597 | -91 |
| Other Working Capital | 6,096 | 6,980 | 4,898 | 5,725 | -791 |
| Other Operating Activity | 653 | -1,878 | 630 | -160 | 1,927 |
| Operating Cash Flow | $-14,388 | $-7,659 | $-4,083 | $2,027 | $-12,706 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -560 | -323 | -125 | -68 | -621 |
| Investing Cash Flow | $-560 | $-323 | $-125 | $-68 | $-621 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -1,158 |
| Common Stock Issued | 15,221 | N/A | 15,281 | N/A | 25,774 |
| Other Financing Activity | 0 | 15,221 | 0 | 0 | 0 |
| Financing Cash Flow | $15,221 | $15,221 | $15,281 | $N/A | $24,616 |
| Exchange Rate Effect | -267 | -31 | -47 | -119 | -415 |
| Beginning Cash Position | 29,350 | 29,349 | 29,349 | 29,349 | 18,474 |
| End Cash Position | 29,356 | 36,558 | 40,374 | 31,189 | 29,349 |
| Net Cash Flow | $6 | $7,209 | $11,025 | $1,839 | $10,875 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,388 | -7,659 | -4,083 | 2,027 | -12,706 |
| Capital Expenditure | -560 | -323 | -125 | -68 | -621 |
| Free Cash Flow | -14,948 | -7,981 | -4,208 | 1,959 | -13,326 |